IFP Advisors’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
MFS
6CM
KGAMU
WPM
IFP Advisors's CDLX Position: Q1 2025 in Review
IFP Advisors held its Cardlytics (CDLX) position steady in Q1 2025 at 0 shares worth $76. The position accounts for ﹤0.01% of the portfolio, ranked #3934.
IFP Advisors first reported a position in CDLX in Q1 2022 and has held it in 3 quarters since. The position peaked at $3K in Q3 2022. 108 funds tracked by Wall St. Rank hold CDLX as of Q1 2025.
- IFP Advisors held 0 shares of Cardlytics worth $76 as of Q1 2025.
- IFP Advisors left its Cardlytics share count unchanged in Q1 2025.
- Cardlytics made up ﹤0.01% of IFP Advisors's portfolio in Q1 2025, its #3934 holding.
- IFP Advisors first reported a position in Cardlytics in Q1 2022 and has held it in 3 quarters since.
- IFP Advisors's Cardlytics position peaked at $3K in Q3 2022.
- 108 funds tracked by Wall St. Rank held Cardlytics as of Q1 2025.
Based on IFP Advisors's 13F filing for Q1 2025, filed 5 May 2025.